Evidence map›Paper›PMID 27884845›Full record

ArticleBMJ open2016

Prevalence and determinants of carotid plaque in the cross-sectional REFINE-Reykjavik study.

Ran Sturlaugsdottir, Thor Aspelund, Gudlaug Bjornsdottir, Sigurdur Sigurdsson, Bolli Thorsson, Gudny Eiriksdottir, Vilmundur Gudnason

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMJ open, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06230705 (Community Intervention to impRove CVD Risk Factor controL in Young AmErican Indians), which is not on this map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06230705 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Community Intervention to impRove CVD Risk Factor controL in Young AmErican Indians: The CIRCLE Study

TypeinterventionalSponsorUniversity of OklahomaRan2025 to 2029Enrolled360ConditionsCholesterol, Elevated, Diabetes MellitusArmsGuided management, Self management
3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 88 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Prevalence and Burden of Carotid and Femoral Atherosclerosis in Subjects Without Known Cardiovascular Disease in a Large Community Hospital in South-America.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Low-grade carotid artery stenosis is associated with progression of brain atrophy and cognitive decline. The SMART-MR study.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Article
  18. Article
  19. Article
  20. Pathophysiology of Atherosclerosis.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ran SturlaugsdottirIcelandic Heart Association, Kopavogur, Iceland.
Thor AspelundIcelandic Heart Association, Kopavogur, Iceland.
Gudlaug BjornsdottirIcelandic Heart Association, Kopavogur, Iceland.
Sigurdur SigurdssonIcelandic Heart Association, Kopavogur, Iceland.
Bolli ThorssonIcelandic Heart Association, Kopavogur, Iceland.
Gudny EiriksdottirIcelandic Heart Association, Kopavogur, Iceland.
Vilmundur GudnasonIcelandic Heart Association, Kopavogur, Iceland.
Icelandic Heart Association · ISUniversity of Iceland · IS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveCarotid plaque and intima-media thickness are non-invasive arterial markers that are used as surrogate end points for cardiovascular disease. The aim was to assess the prevalence and severity of carotid plaque, and examine its determinant risk factors and their association to the common carotid artery intima-media thickness (CCA-IMT) in a general population.

methodsWe examined 6524 participants aged 25-69 years in the population-based REFINE (Risk Evaluation For INfarct Estimates)-Reykjavik study. Plaques at the bifurcation and internal carotid arteries were evaluated. Mean CCA-IMT was measured in the near and far walls of the common carotid arteries.

resultsThe prevalence of minimal, moderate and severe plaque was 35.0%, 8.9% and 1.1%, respectively, and the mean CCA-IMT was 0.73 (SD 0.14) mm. Age, sex, smoking and type 2 diabetes mellitus (T2DM) were the strongest risk factors associated with plaque, followed by systolic blood pressure, total cholesterol, body mass index and family history of myocardial infarct. Low educational level was also strongly and independently associated with plaque. CCA-IMT shared the same risk factors except for a non-significant association with T2DM and family history of myocardial infarction (MI). Participants with T2DM had greater plaque prevalence, 2-fold higher in those <50 years and 17-30% greater in age groups 50-54 to 60-64, and more significant plaques (moderate or severe) were the difference in prevalence was 24% in age group 50-54 and ≥60% in older age groups, compared with non-T2DM.

conclusionsCarotid plaque and CCA-IMT have mostly common determinants. However, T2DM and family history of MI were associated with plaque but not with CCA-IMT. Greater prevalence and more severe plaques in individuals with T2DM raise the concern that with increasing prevalence of T2DM we may expect an increase in atherosclerosis and its consequences.

Indexed as

AdultAge DistributionAtherosclerosisBlood PressureCarotid Artery, CommonCarotid Intima-Media ThicknessCholesterolCross-Sectional StudiesDiabetes Mellitus, Type 2FemaleHumansIcelandLogistic ModelsMaleMiddle AgedRisk FactorsCholesterolatherosclerosiscarotid arteriesrisk factorstype 2 diabetes mellitus

Identifiers

PMID27884845
PMCPMC5168519
OpenAlexW2556056113

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.